Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials

Brooke M. Felsheim, Jens Huober, Lisa A. Carey, Valentina Nekljudova, Thomas Karn, Sara M. Tolaney, Andreas Schneeweiss, Michael Untch, Christoph Salat, Charles S. Kuzma, Aranzazu Fernandez-Martinez, Sivaramakrishna Rachakonda, Jose J. Ponce-Lorenzo, Dirk-Michael Zahm, Rama Suresh, Daniel G. Stover, Priya Rastogi, Maren Darsow, Diana E. Lake, Hope S. Rugo, Joyce O'Shaughnessy, Mehra Golshan, Adam D. Pfefferle, William M. Sikov, Otto Metzger, Carsten Denkert, Charles E. Geyer, Charles M. Perou, Sibylle Loibl

Open source

DOI: 10.1200/oa-26-00101
Published: 2026-10
Container: JCO Oncology Advances
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/oa-26-00101,
  title = {Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials},
  author = {Brooke M. Felsheim and Jens Huober and Lisa A. Carey and Valentina Nekljudova and Thomas Karn and Sara M. Tolaney and Andreas Schneeweiss and Michael Untch and Christoph Salat and Charles S. Kuzma and Aranzazu Fernandez-Martinez and Sivaramakrishna Rachakonda and Jose J. Ponce-Lorenzo and Dirk-Michael Zahm and Rama Suresh and Daniel G. Stover and Priya Rastogi and Maren Darsow and Diana E. Lake and Hope S. Rugo and Joyce O'Shaughnessy and Mehra Golshan and Adam D. Pfefferle and William M. Sikov and Otto Metzger and Carsten Denkert and Charles E. Geyer and Charles M. Perou and Sibylle Loibl},
  year = {2026},
  journal = {JCO Oncology Advances},
  doi = {10.1200/oa-26-00101},
  url = {https://doi.org/10.1200/oa-26-00101}
}

RIS

TY  - JOUR
TI  - Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials
AU  - Brooke M. Felsheim
AU  - Jens Huober
AU  - Lisa A. Carey
AU  - Valentina Nekljudova
AU  - Thomas Karn
AU  - Sara M. Tolaney
AU  - Andreas Schneeweiss
AU  - Michael Untch
AU  - Christoph Salat
AU  - Charles S. Kuzma
AU  - Aranzazu Fernandez-Martinez
AU  - Sivaramakrishna Rachakonda
AU  - Jose J. Ponce-Lorenzo
AU  - Dirk-Michael Zahm
AU  - Rama Suresh
AU  - Daniel G. Stover
AU  - Priya Rastogi
AU  - Maren Darsow
AU  - Diana E. Lake
AU  - Hope S. Rugo
AU  - Joyce O'Shaughnessy
AU  - Mehra Golshan
AU  - Adam D. Pfefferle
AU  - William M. Sikov
AU  - Otto Metzger
AU  - Carsten Denkert
AU  - Charles E. Geyer
AU  - Charles M. Perou
AU  - Sibylle Loibl
PY  - 2026
JO  - JCO Oncology Advances
DO  - 10.1200/oa-26-00101
UR  - https://doi.org/10.1200/oa-26-00101
ER  -

APA

Felsheim, B. M., Huober, J., Carey, L. A., Nekljudova, V., Karn, T., Tolaney, S. M., Schneeweiss, A., Untch, M., Salat, C., Kuzma, C. S., Fernandez-Martinez, A., Rachakonda, S., Ponce-Lorenzo, J. J., Zahm, D., Suresh, R., Stover, D. G., Rastogi, P., Darsow, M., Lake, D. E., Rugo, H. S., O'Shaughnessy, J., Golshan, M., Pfefferle, A. D., Sikov, W. M., Metzger, O., Denkert, C., Geyer, C. E., Perou, C. M., & Loibl, S. (2026). Impact of Neoadjuvant Carboplatin in Early-Stage Triple-Negative Breast Cancer: A Pooled Analysis of the BrighTNess, Cancer and Leukemia Group B 40603 (Alliance), and GeparSixto Clinical Trials. JCO Oncology Advances. https://doi.org/10.1200/oa-26-00101

Source records

crossref · retrieved 2026-11-07T23:22:28.439Z